Drug Trials Snapshot - VERQUVO

A new DRUG TRIALS SNAPSHOT is now available. VERQUVO is a drug used to reduce the risk of dying and hospitalization in patients with chronic (long-lasting) heart failure. Heart failure is a condition when the heart is not pumping as well as it should be. VERQUVO is a tablet that is taken by mouth once a day. VERQUVO is used in patients who are having symptoms of chronic heart failure and who have had a recent hospitalization or the need to receive intravenous medicines.   See more Drug Trials Snapshots or contact us with questions at Snapshots@fda.hhs.gov     Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA